| Stragen Pharma SA - Urapidil Stragen i.v. 50 mg, solution injectable |
| 66012 | | 02 | | Urapidil Stragen i.v. 50 mg | | solution injectable | | C02CA06 | | Urapidil | | 21.04.2016 | | |
|
| Composition |
| urapidilum 50 mg, acidum hydrochloridum concentratum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, propylenglycolum 1000 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 4.36 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Urapidil | 50mg / 10ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum | | | Acidum Hydrochloridum Concentratum | | | Disodium Phosphate Dihydrate | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydroxide | | | Propylenglycol | 1000mg / 10ml |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 5 x 10 ml | DDP | DDP | B | | Oui |
|
